The Peony trial: adding evidence to pertuzumab use in non-metastatic breast cancer
- PMID: 32953622
- PMCID: PMC7475362
- DOI: 10.21037/gs.2020.03.11
The Peony trial: adding evidence to pertuzumab use in non-metastatic breast cancer
Conflict of interest statement
Conflicts of Interest: Both authors have completed the ICMJE uniform disclosure form (available at http://dx.doi.org/10.21037/gs.2020.03.11). The authors have no conflicts of interest to declare.
Comment on
-
Efficacy, Safety, and Tolerability of Pertuzumab, Trastuzumab, and Docetaxel for Patients With Early or Locally Advanced ERBB2-Positive Breast Cancer in Asia: The PEONY Phase 3 Randomized Clinical Trial.JAMA Oncol. 2020 Mar 1;6(3):e193692. doi: 10.1001/jamaoncol.2019.3692. Epub 2020 Mar 12. JAMA Oncol. 2020. PMID: 31647503 Free PMC article. Clinical Trial.
References
Publication types
LinkOut - more resources
Full Text Sources